| Table 3. Mean ± SD of the number of primordial, primary, secondary, antral, atretic follicles and corpus luteum of rats in different groups | ||||||
| Groups | Parameter | |||||
| Primordial | Primary | Secondary | Antral | Atretic | Corpus luteum | |
| Group A | 1.35±2.4 | 2.24±1.6 | 4.45±0.7a | 0.38±1.7a | 1.45±0.5a | 8.4±1.1a |
| Group B | 1.12±2.0 | 2.11±1.4 | 2.61±2.0a | 0.11±2.1a | 2.87±0.7a | 5.22±1.1a,b,c,d |
| Group C | 1.14±1.1 | 2.12±1.2 | 4.32±2.1 | 0.25±0.9 | 1.90±1.2 | 7.71±2.1b |
| Group D | 1.27±0.6 | 2.17±1.5 | 4.5±0.3 | 0.29±1.3 | 0.98±1.3 | 7.98±0.9c |
| Group E | 1.20±1.5 | 2.16±0.5 | 4.37±2.1 | 0.30±0.7 | 1.39±1.4 | 8.05±0.7d |
| Same superscript in each column indicate
significant differences at p<0.05. Group (A) which served as the control group and received a daily oral gavage normal saline Group (B) diabetic rats, which received streptozotocin. Group (C) diabetic rats were administered P. atlantica extract (200 mg/kg) daily by gavage. Group (D) non-diabetic rats received similar doses of P. atlantica extract alone. Group (E) diabetic rats were administered glibenclamide (200 mg/kg) daily by gavage. |
||||||